before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this drug, and they will ...

After that documentary aired ... thriving on social media. It was not long before I was being swamped with adverts with thumping dance music blaring in the background, and text like "drop a ...

Zarxio – the first US biosimilar After a very long wait ... it will take a number of years before more substantial savings are offered, as acceptance of biosimilars grows and more products ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

After 1,203 episodes, "WWE Raw" signed off from the USA Network on Monday night. It was a jam-packed final episode before the show shifts, in a landmark move, on Jan. 6 to Netflix. With more than ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Professor Kamila Hawthorne, chairman of the Royal College of GPs, said she had 'serious concerns' about drugs sold by ...

But investors were yesterday disappointed with the results of a trial for its next weight loss drug – a combination of Wegovy and another of its drugs, Saxenda. Novo Nordisk had been hoping ...